Read The Letter That Canopy Growth's CEO Wrote About Charlotte Figi And Her Legacy

Comments
Loading...

David Klein, CEO of Canopy Growth Corp (NYSE CGC), shared a letter today, reflecting on the passing of Charlotte Figi and her impact on the industry.

The letter, below:

April 14th, 2020

I’ve spent the past several days reading heartfelt tributes to Charlotte Figi from some of the most influential voices in healthcare and cannabis, contemplating the impact one extraordinary child made on the lives of millions. From the age of five, she captured the attention of medical leaders and the hearts of skeptics, becoming the catalyst that would bring cannabis and CBD from the fringe to the forefront.

Charlotte was living proof that CBD is a legitimate and powerful medicine, and reminded us that we’ve only just begun to understand the vast, untapped potential of cannabis and hemp. Epidolex, the groundbreaking FDA-approved cannabinoid seizure medication she inspired, is merely the tip of the iceberg. Charlotte inspired pioneering minds around the world to ask, “if using CBD can help a five year-old child overcome a catastrophic condition like Dravet syndrome, what else can this plant do to improve people’s physical health and emotional wellness?

At Canopy Growth, we’re driven to find the answers. We devote our days to conducting robust clinical research, developing innovative products, advocating for patients and educating both practitioners and consumers. Public opinion has certainly come a long way since Charlotte first put a human face on the case for medical cannabis nine years ago, but there is still much work to be done.

Charlotte is now, in the words of her mother Paige, “forever seizure free,” but her life has left an indelible mark. She will be remembered as the spark that enlightened minds, changed laws and inspired an industry. In the words of Dr. Sanjay Gupta, one of her most dedicated supporters, “Charlotte Figi was more than an individual, she was an entire movement.”

David Klein, CEO, Canopy Growth Corporation.

Versión en Español en El Planteo.

Photo via Charlotte's Web.

The preceding article is from one of our external contributors. It does not represent the opinion of Benzinga and has not been edited.

CGC Logo
CGCCanopy Growth Corp
$0.8699-3.14%

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score
Edge Rankings
Momentum
1.87
Growth
7.55
Quality
-
Value
82.67
Price Trend
Short
Medium
Long
Market News and Data brought to you by Benzinga APIs

Posted In:

Cannabis is evolving—don’t get left behind!

Curious about what’s next for the industry and how to stay ahead in today’s competitive market?

Join top executives, investors, and industry leaders at the Benzinga Cannabis Capital Conference in Chicago on June 9-10. Dive deep into market-shaping strategies, investment trends, and brand-building insights that will define the future of cannabis.

Secure your spot now before prices go up—this is where the biggest deals and connections happen!

Get your tickets today!